Skip to main content
Gufic BioSciences Ltd. logo

Gufic BioSciences Ltd. — Investor Relations & Filings

Ticker · GUFICBIO ISIN · INE742B01025 LEI · 3358003C6YDH6EIDBP63 BSE.NS Manufacturing
Open in API
Filings indexed 1,192 across all filing types
Latest filing 2025-11-14 Investor Presentation
Country IN India
Listing BSE.NS GUFICBIO

About Gufic BioSciences Ltd.

https://gufic.com/

Gufic BioSciences Ltd. focuses on the research, development, and large-scale manufacturing of pharmaceutical formulations and active pharmaceutical ingredients. The organization is distinguished by its specialized expertise in lyophilization technology, operating extensive facilities for the production of freeze-dried injectables. Its product portfolio encompasses a wide range of therapeutic areas, including critical care, infertility, oncology, and gastroenterology. In addition to conventional medicine, the company develops proprietary herbal and ayurvedic formulations through integrated scientific research. Gufic emphasizes advanced drug delivery systems and maintains a significant presence in the production of antibiotics, antifungal agents, and cardiac medications. The company serves a global clientele by providing high-quality generic and specialty healthcare solutions.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and is addressed to stock exchanges referencing Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It explicitly states it is an Investor Presentation on Unaudited Financial Results for the quarter and half year ended September 30, 2025. The content includes detailed business and financial highlights, operational updates, product pipeline, and strategic outlook, typical of investor presentations. The document length is substantial (15,000 characters), indicating it is the presentation itself, not just an announcement of its availability. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. Therefore, the document fits the category of an Investor Presentation (IP).
2025-11-14 English
Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2025 is attached herewith.
Regulatory Filings
2025-11-14 English
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform ....
Regulatory Filings
2025-11-14 English
Outcome of Board Meeting
Regulatory Filings
2025-11-14 English
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to ....
Call Transcript Classification · 95% confidence The document is a notification about an upcoming earnings conference call scheduled for November 17, 2025. It includes details such as the date, time, dial-in numbers, and a pre-registration link. The text explicitly states that the call will discuss business background, prospects, and financial performance, but this document itself is only an announcement of the call, not the transcript or financial results. The document length is short (2187 characters), and it serves as an invitation/intimation rather than containing actual financial data or a transcript. Therefore, it fits the category of a Call Transcript announcement, but since it is not the transcript itself, it is best classified as a Call Transcript (CT) type document, as per the definitions, this is the closest match for an earnings call announcement. Confidence is high due to clear keywords and regulatory references.
2025-11-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a notification addressed to stock exchanges about an upcoming earnings conference call scheduled for November 17, 2025. It references the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating regulatory compliance. The content includes details about the call timing, dial-in numbers, and a pre-registration link. The document does not contain any financial data, analysis, or results itself, but rather serves as an announcement of the event where such information will be discussed. The document length is short (2187 characters), and it explicitly states the purpose is to inform about the earnings call, not to present the earnings report or transcript. Therefore, this fits the category of a Call Transcript announcement or invitation, but since it is only an invitation and not the transcript itself, the best matching category is Call Transcript (CT) as it relates to the earnings call event. Confidence is high due to clear keywords and regulatory references.
2025-11-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.